The need for histological subclassification of cirrhosis: A systematic review and meta-analysis

Gaeun Kim, Samuel S. Lee, Soon Koo Baik, Youn Zoo Cho, Moon Young Kim, Sang Ok Kwon, Seung Hwan Cha, Mee Yon Cho

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background & Aims: The need for further histological subclassification of cirrhosis has been increasingly recognized because of the heterogeneity of severity within cirrhosis. We sought to identify evidence in the literature regarding the histological subclassification of cirrhosis using the Laennec stage. Methods: We conducted a systematic review and meta-analysis by searching databases, including MEDLINE, EMBASE and the COCHRANE library, for relevant studies. Results: Of 208 studies identified, 16 were eligible according to the inclusion criteria. With higher grades of the Laennec stage, clinical stages of cirrhosis and Child-Pugh scores/Model for end-stage liver disease scores increased (P < 0.05). Higher Laennec stages were statistically associated with the development of liver-related events, such as liver-related death, liver cancer progression and variceal haemorrhage, as well as higher hepatic venous pressure gradients and higher liver stiffness values (P < 0.05). Two open-labelled studies showed the usefulness of the Laennec system with regard to the evaluation of whether antifibrotic treatments were effective. The mean kappa value was 0.81 (range 0.61-0.87) for inter-observer agreement. Conclusions: Based on this systematic review and meta-analysis, histological subclassification of cirrhosis using the Laennec system is useful to better predict prognosis and complications of portal hypertension.

Original languageEnglish
Pages (from-to)847-855
Number of pages9
JournalLiver International
Volume36
Issue number6
DOIs
Publication statusPublished - 2016 Jun 1

Fingerprint

Meta-Analysis
Fibrosis
Liver
End Stage Liver Disease
Venous Pressure
Portal Hypertension
Liver Neoplasms
MEDLINE
Libraries
Databases
Hemorrhage
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Kim, Gaeun ; Lee, Samuel S. ; Baik, Soon Koo ; Cho, Youn Zoo ; Kim, Moon Young ; Kwon, Sang Ok ; Cha, Seung Hwan ; Cho, Mee Yon. / The need for histological subclassification of cirrhosis : A systematic review and meta-analysis. In: Liver International. 2016 ; Vol. 36, No. 6. pp. 847-855.
@article{2c3086838b1d4f27ab9b4d86c2c1d9a6,
title = "The need for histological subclassification of cirrhosis: A systematic review and meta-analysis",
abstract = "Background & Aims: The need for further histological subclassification of cirrhosis has been increasingly recognized because of the heterogeneity of severity within cirrhosis. We sought to identify evidence in the literature regarding the histological subclassification of cirrhosis using the Laennec stage. Methods: We conducted a systematic review and meta-analysis by searching databases, including MEDLINE, EMBASE and the COCHRANE library, for relevant studies. Results: Of 208 studies identified, 16 were eligible according to the inclusion criteria. With higher grades of the Laennec stage, clinical stages of cirrhosis and Child-Pugh scores/Model for end-stage liver disease scores increased (P < 0.05). Higher Laennec stages were statistically associated with the development of liver-related events, such as liver-related death, liver cancer progression and variceal haemorrhage, as well as higher hepatic venous pressure gradients and higher liver stiffness values (P < 0.05). Two open-labelled studies showed the usefulness of the Laennec system with regard to the evaluation of whether antifibrotic treatments were effective. The mean kappa value was 0.81 (range 0.61-0.87) for inter-observer agreement. Conclusions: Based on this systematic review and meta-analysis, histological subclassification of cirrhosis using the Laennec system is useful to better predict prognosis and complications of portal hypertension.",
author = "Gaeun Kim and Lee, {Samuel S.} and Baik, {Soon Koo} and Cho, {Youn Zoo} and Kim, {Moon Young} and Kwon, {Sang Ok} and Cha, {Seung Hwan} and Cho, {Mee Yon}",
year = "2016",
month = "6",
day = "1",
doi = "10.1111/liv.12923",
language = "English",
volume = "36",
pages = "847--855",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "6",

}

The need for histological subclassification of cirrhosis : A systematic review and meta-analysis. / Kim, Gaeun; Lee, Samuel S.; Baik, Soon Koo; Cho, Youn Zoo; Kim, Moon Young; Kwon, Sang Ok; Cha, Seung Hwan; Cho, Mee Yon.

In: Liver International, Vol. 36, No. 6, 01.06.2016, p. 847-855.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The need for histological subclassification of cirrhosis

T2 - A systematic review and meta-analysis

AU - Kim, Gaeun

AU - Lee, Samuel S.

AU - Baik, Soon Koo

AU - Cho, Youn Zoo

AU - Kim, Moon Young

AU - Kwon, Sang Ok

AU - Cha, Seung Hwan

AU - Cho, Mee Yon

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Background & Aims: The need for further histological subclassification of cirrhosis has been increasingly recognized because of the heterogeneity of severity within cirrhosis. We sought to identify evidence in the literature regarding the histological subclassification of cirrhosis using the Laennec stage. Methods: We conducted a systematic review and meta-analysis by searching databases, including MEDLINE, EMBASE and the COCHRANE library, for relevant studies. Results: Of 208 studies identified, 16 were eligible according to the inclusion criteria. With higher grades of the Laennec stage, clinical stages of cirrhosis and Child-Pugh scores/Model for end-stage liver disease scores increased (P < 0.05). Higher Laennec stages were statistically associated with the development of liver-related events, such as liver-related death, liver cancer progression and variceal haemorrhage, as well as higher hepatic venous pressure gradients and higher liver stiffness values (P < 0.05). Two open-labelled studies showed the usefulness of the Laennec system with regard to the evaluation of whether antifibrotic treatments were effective. The mean kappa value was 0.81 (range 0.61-0.87) for inter-observer agreement. Conclusions: Based on this systematic review and meta-analysis, histological subclassification of cirrhosis using the Laennec system is useful to better predict prognosis and complications of portal hypertension.

AB - Background & Aims: The need for further histological subclassification of cirrhosis has been increasingly recognized because of the heterogeneity of severity within cirrhosis. We sought to identify evidence in the literature regarding the histological subclassification of cirrhosis using the Laennec stage. Methods: We conducted a systematic review and meta-analysis by searching databases, including MEDLINE, EMBASE and the COCHRANE library, for relevant studies. Results: Of 208 studies identified, 16 were eligible according to the inclusion criteria. With higher grades of the Laennec stage, clinical stages of cirrhosis and Child-Pugh scores/Model for end-stage liver disease scores increased (P < 0.05). Higher Laennec stages were statistically associated with the development of liver-related events, such as liver-related death, liver cancer progression and variceal haemorrhage, as well as higher hepatic venous pressure gradients and higher liver stiffness values (P < 0.05). Two open-labelled studies showed the usefulness of the Laennec system with regard to the evaluation of whether antifibrotic treatments were effective. The mean kappa value was 0.81 (range 0.61-0.87) for inter-observer agreement. Conclusions: Based on this systematic review and meta-analysis, histological subclassification of cirrhosis using the Laennec system is useful to better predict prognosis and complications of portal hypertension.

UR - http://www.scopus.com/inward/record.url?scp=84940706520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940706520&partnerID=8YFLogxK

U2 - 10.1111/liv.12923

DO - 10.1111/liv.12923

M3 - Article

C2 - 26212153

AN - SCOPUS:84940706520

VL - 36

SP - 847

EP - 855

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 6

ER -